SEMICON Taiwan 2025, the international semiconductor exhibition, opened today (10th) at the Nangang Exhibition Center. Taiya Semiconductor (2340), together with its subsidiaries, Asia Intelligent (7825), Asia Semiconductor (7787), and Crown Asia Semiconductor, showcased their latest R&D achievements. Taiya Semiconductor officially announced its HUSD (Hybrid Ultra Sensing Device) technology, demonstrating the innovative application of semiconductors in smart healthcare. HUSD is an optical sensing technology developed by Taiya specifically for non-invasive blood glucose monitoring. It integrates multiple high-density SWIR (short-wave infrared) composite elements and combines them with surface optical multilayer film technology to drive new application scenarios for high-precision non-invasive blood glucose monitoring wearable devices. This breakthrough ushers in a new era of blood glucose monitoring.
At SEMICON Taiwan 2025, Taiya Semiconductor officially launched its HUSD technology, showcasing innovative applications of semiconductors in smart healthcare. (Photo courtesy of Taiya Semiconductor)
Taiya Semiconductor stated that it provides highly accurate blood glucose monitoring solutions, making daily blood sugar control more convenient. With the support of the government's "A+ Enterprise Innovation R&D Refinement Program," Taiya Semiconductor has planned a complete HUSD technology development roadmap, demonstrating a clear strategy and determination to gradually move towards medical applications. It plans to launch the HUSD-HS2 (Healthcare Series 2) module this year, with an average MARD (mean error rate) of approximately 15% in preclinical testing, already supporting wearable applications for daily health management. Next year, it plans to launch the HUSD-HS3, with an error rate reduced to below 10%, coupled with AI algorithms, to reach the threshold for clinical use. Ultimately, it plans to develop the HUSD-MS (Medical Series) to enter the medical-grade blood glucose monitoring market.
In addition, Taiya Semiconductor will host an industry exchange meeting on September 11th in partnership with Jicheng Capital, bringing together senior executives, strategic partners, investors, and customers from the semiconductor industry to discuss cross-domain cooperation and investment opportunities. At the meeting, Taiya Semiconductor will present a keynote speech titled "Driving High-Precision NICGM Innovation with Compound Semiconductor SWIR HUSD Sensing Technology," and Professor Hsieh Jung-Hung, Dean of the College of Nutrition at Taipei Medical University, will speak on "Non-invasive Continuous Glucose Monitoring: A Health Revolution in Everyday Life," analyzing the applications and future development of HUSD from both industry and medical perspectives.
Tai Chen-Chia, Vice Chairman of Tai-A Semiconductor and Managing Director of Nichia Chemical, stated, "Tai-A Semiconductor has been deeply involved in the field of sensing components for 40 years. After a period of active transformation, HUSD represents a significant breakthrough for Tai-A Semiconductor in optical sensing technology. This technology enables blood glucose monitoring without needles or consumables, truly integrating health monitoring into daily life. We will first implement it in wearable applications, gradually optimize accuracy, and ultimately challenge medical-grade monitoring, achieving a perfect combination of semiconductor technology and medical needs." With the increasing global health awareness, the demand for non-invasive blood glucose monitoring is growing rapidly. Tai-A Semiconductor is strategically positioning itself for cross-domain innovation in "sensing semiconductors × smart healthcare," accelerating the commercialization and internationalization of HUSD technology, and outlining its core vision of smart healthcare, a healthy Taiwan, and sustainable development.
